Therapeutic Innovation Australia

Established in 2008, Therapeutic Innovation Australia (TIA) is the lead agent for the [National Collaborative Research Infrastructure Strategy (NCRIS)](https://therapeuticinnovation.com.au/leadership-and-strategy/#) “Therapeutic Innovation Australia” project funded by the Australian Department of Education. TIA supports national research infrastructure across four capabilities : - Biologics & Vaccines - Cell & Gene Therapies - Small Molecule Therapeutics - RNA Products **Strategic Plan** We have developed a [Strategic Plan](https://therapeuticinn.wpengine.com/wp-content/uploads/2023/08/TIA-2023-28-Strategic-Plan.pdf) for the period 2023-2028 that outlines key strategic aims associated with support of a network of Australian translational research infrastructure. **Vision** For the Australian research community to have access to world class research infrastructure to enable efficient translation of therapeutics to improve human health. **Mission** TIA will enable and accelerate the translation of research discovery along the therapeutic development pipeline by investing in world class research infrastructure facilities so they are coordinated, comprehensive, accessible and responsive to the needs of the Australian translational research community.